Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO.2 TO FORM S-1 - ENANTA PHARMACEUTICALS INC | d401292ds1a.htm |
| EX-10.2 - COLLABORATION & LICENSE AGREEMENT - ENANTA PHARMACEUTICALS INC | d401292dex102.htm |
| EX-10.1 - COLLABORATIVE DEVELOPMENT & LICENSE AGREEMENT - ENANTA PHARMACEUTICALS INC | d401292dex101.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 2 to the Registration Statement on Form S-1 of Enanta Pharmaceuticals, Inc. of our report dated November 16, 2012, relating to the financial statements of Enanta Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
December 17, 2012